The primary endpoint was the percentage change in bodyweight from baseline to week 46
We confirmed that this product is FDA cleared [249] and has supporting literature demonstrating the ability to replace, reduce, or avoid intraoperative or postoperative opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer reviewed journal
Gonadotropin releasing hormone (GnRH) from the hypothalamus stimulates the anterior pituitary gland to release gonadotropinsfollicle stimulating hormone (FSH) and luteinizing hormone (LH)
These devices represent a leap forward from the traditional syringe-and-needle approach, providing a less invasive method of drug delivery
Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis
Risk of infection, air embolism, and anaphylaxis precludes self-administration